ArticleJournal of the American Geriatrics Society2022
Comparing the care experiences of Medicare Advantage beneficiaries with and without Alzheimer's disease and related dementias.
Article in Journal of the American Geriatrics Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 13 citations in OpenAlex.
- Comparing Health Care Utilization Between Medicare Advantage and Traditional Medicare by Dementia Status: A Propensity-Weighted Analysis.Health services research · 2026Observational
- Identification of prevalent dementia in Medicare Advantage encounters, compared with rigorous cohort assessments.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026Article
- Patient-Driven Grouping Model and Home Health Use Among Traditional Medicare Beneficiaries.Journal of the American Medical Directors Association · 2026Article
- National trends in the prevalence of dementia in Medicare Advantage and Traditional Medicare.BMC health services research · 2026Article
- Risk Adjustment for Alzheimer Disease and Related Dementias in Medicare Advantage and Health Care Experiences.JAMA network open · 2026Article
- Decomposing Medicare total, Part D, and Part B drug payments among people with Alzheimer's disease and related diseases.Health affairs scholar · 2025Article
- Top-Rated Health Care and Ease of Access to Medications Linked to Lower Medicare and ADRD Costs.Medical care · 2025Article
- Patterns of national emergency department utilization by fee-for-service Medicare beneficiaries with dementia.Journal of the American Geriatrics Society · 2024Article
- Medicare Advantage enrollment and outcomes of post-acute nursing home care among patients with dementia.Health affairs scholar · 2024Article
- Medicare Advantage Enrollment and Disenrollment Among Persons With Alzheimer Disease and Related Dementias.JAMA health forum · 2023Article
- Addressing Serious Illness Care in Medicare Advantage.The New England journal of medicine · 2023Article
- Functional and clinical needs of older hospice enrollees with coexisting dementia.Journal of the American Geriatrics Society · 2023Article
- Variations in Medicare Advantage Switching Rates Among African American and Hispanic Medicare Beneficiaries With Alzheimer's Disease and Related Dementias, by Sex and Dual Eligibility.The journals of gerontology. Series B, Psychological sciences and social sciences · 2022Article
- Ready or Not: A Conceptual Model of Organizational Readiness for Embedded Pragmatic Dementia Research.Research in gerontological nursingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundThe Medicare Advantage (MA) program is rapidly growing. Limited evidence exists about the care experiences of MA beneficiaries with Alzheimer's Disease and Related Dementia (ADRD). Our objective was to compare care experiences for MA beneficiaries with and without ADRD.
methodsWe examined MA beneficiaries who completed the Medicare Advantage Consumer Assessment of Healthcare Providers and Systems (CAHPS) and used inpatient, nursing home, or home health services in the past 3 years. We classified beneficiaries with ADRD using the presence of diagnosis codes in hospitals, nursing homes, and home health records. Our key measures included overall ratings of care and health plan, and indices of receiving timely care, care coordination, receiving needed care, and customer service. We compared differences between beneficiaries with and without ADRD using regression analysis adjusting for demographic, health, and plan characteristics, and stratifying by proxy response status.
resultsAmong beneficiaries sampled by CAHPS, 22.2% with ADRD completed the survey compared to 38.5% without ADRD. Among proxy responses, beneficiaries with ADRD were 4.2 (95% CI: 0.1-8.4) percentage points less likely to report a high score for receiving needed care, and 3.5 percentage points (95% CI: 0.2-6.9) less likely to report a high score for customer service. Among non-proxy responses, those with ADRD were 9.0 (95% CI: 5.5-12.5) percentage points less likely to report a high score for needed care, and 8.5 (95% CI: 5.4-11.5) percentage points less likely to report a high score for customer service.
conclusionsADRD respondents to the CAHPS were more likely to be excluded from CAHPS performance measures because they did not meet eligibility requirements and rates of non-response were higher. Among responders with or without a proxy, MA enrollees with an ADRD diagnosis reported worse care experiences in receiving needed care and in customer service than those without an ADRD diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.